Sandbox:Shadan: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 8: | Line 8: | ||
==Classification== | ==Classification== | ||
'''Classification of [[breast lumps]] based on [[epithelial hyperplasia]]<ref name="pmid16034008">{{cite journal| author=Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K et al.| title=Benign breast disease and the risk of breast cancer. | journal=N Engl J Med | year= 2005 | volume= 353 | issue= 3 | pages= 229-37 | pmid=16034008 | doi=10.1056/NEJMoa044383 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16034008 }} </ref>''' | '''Classification of [[breast lumps]] based on [[epithelial hyperplasia]]<ref name="pmid16034008">{{cite journal| author=Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K et al.| title=Benign breast disease and the risk of breast cancer. | journal=N Engl J Med | year= 2005 | volume= 353 | issue= 3 | pages= 229-37 | pmid=16034008 | doi=10.1056/NEJMoa044383 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16034008 }} </ref>''' | ||
*Approximately 65% of all | *Approximately 65% of all BBD considered as [[nonproliferative]](NP)with relative cancer risk of 1.2, 1.4 times: | ||
**Simple cyst | **Simple cyst | ||
**Fibrosis | **Fibrosis | ||
Line 15: | Line 15: | ||
** Apocrine metaplasia (simple) | ** Apocrine metaplasia (simple) | ||
** Mild ductal hyperplasia | ** Mild ductal hyperplasia | ||
* Approximately 30% of total are classifed as [[proliferative disease(PD) with relative cancer risk of 1.7, 2.1 times | * Approximately 30% of total are classifed as [[proliferative disease]](PD) with relative cancer risk of 1.7, 2.1 times | ||
** Usual ductal hyperplasia | ** Usual ductal hyperplasia | ||
** Sclerosing adenosis | ** Sclerosing adenosis | ||
Line 21: | Line 21: | ||
** papilloma | ** papilloma | ||
** Radical scar | ** Radical scar | ||
* Approximately 5% to 8% of the rest regarded to [[PD with atypia]]with relative cancer risk more than 4 times | * Approximately 5% to 8% of the rest regarded to [[PD with atypia]] with relative cancer risk more than 4 times | ||
** Atypical lobar hyperplasia | ** Atypical lobar hyperplasia | ||
** Lobular carcinoma in situ | ** Lobular carcinoma in situ |
Revision as of 16:23, 6 December 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Overview
Classification
Classification of breast lumps based on epithelial hyperplasia[1]
- Approximately 65% of all BBD considered as nonproliferative(NP)with relative cancer risk of 1.2, 1.4 times:
- Simple cyst
- Fibrosis
- Fibroadenoma (simple)
- Columnar alteration (Simple)
- Apocrine metaplasia (simple)
- Mild ductal hyperplasia
- Approximately 30% of total are classifed as proliferative disease(PD) with relative cancer risk of 1.7, 2.1 times
- Usual ductal hyperplasia
- Sclerosing adenosis
- Columnar hyperplasia
- papilloma
- Radical scar
- Approximately 5% to 8% of the rest regarded to PD with atypia with relative cancer risk more than 4 times
- Atypical lobar hyperplasia
- Lobular carcinoma in situ
- Atypical ductal hyperplasia
- Unclear risk
- Mucocele like tumor
- Apocrine atypia
- Secretory atypia
References
- ↑ Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K; et al. (2005). "Benign breast disease and the risk of breast cancer". N Engl J Med. 353 (3): 229–37. doi:10.1056/NEJMoa044383. PMID 16034008.